When was Neurovative Diagnostics founded?

Neurovative Diagnostics was founded in 2016.

Where is Neurovative Diagnostics located?

Neurovative Diagnostics is headquartered in Dallas, United States.

Who is the current CEO of Neurovative Diagnostics?

Tony Wax of Neurovative Diagnostics. They have also founded 1 company.

How many employees does Neurovative Diagnostics have?

As of Jun 30, 2026, the latest employee count at Neurovative Diagnostics is 44.

Is Neurovative Diagnostics a funded company?

Neurovative Diagnostics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Neurovative Diagnostics rank among its competitors?

Neurovative Diagnostics ranks 70th amongst 138 active competitors, of which 56 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Neurosoft Bioelectronics, which secured $7.5M in May, 2026.

Who are the top competitors of Neurovative Diagnostics?

Neurovative Diagnostics' top competitors include Ceribell, Empatica and Cumulus Neuro. Among them, Neurosoft Bioelectronics secured the most recent funding round in May, 2026.

Neurovative Diagnostics - 2026 Company Profile, Team & Competitors

Neurovative Diagnostics is an unfunded company based in Dallas (United States), founded in 2016 by Tony Wax. It operates as a Provider of cloud-based neurodiagnostic software for clinicians. Neurovative Diagnostics has not raised any funding yet. The company has 138 active competitors, including 56 funded and 5 that have exited. Its top competitors include companies like Ceribell, Empatica and Cumulus Neuro.

Company Details

Neurovative provides cloud-based neurodiagnostic software for clinicians. It provides an in-home ambulatory electroencephalogram with a video. Ambulatory electroencephalogram with video is a neurodiagnostic test that measures and records the electrical activity of the brain using electrodes that are placed on the scalp.

Website: neurovativediagnostics.com
Social
Email ID: *****@neurovativediagnostics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Dallas, United States

Stage

Unfunded

Ranked

70^th among 138 active competitors

Employee Count

44 as on Jun 30, 2026

Similar Companies

Ceribell & 142 more

View Neurovative Diagnostics' full profile

Neurovative Diagnostics has not raised any funding rounds yet.

The founders of Neurovative Diagnostics is Tony Wax. Tony Wax is the CEO of Neurovative Diagnostics.

Here are the details of Neurovative Diagnostics' key team members:

Tony Wax: Co-Founder & CEO of Neurovative Diagnostics.
Contact Info: 1 email address

View details of Neurovative Diagnostics's Founder profiles and Board Members

Neurovative Diagnostics' employee count trend

Neurovative Diagnostics has 44 employees as of Jun 26. Here is Neurovative Diagnostics's employee count trend over the years:

Employee count trend for Neurovative Diagnostics

Uncover Neurovative Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neurovative Diagnostics include Ceribell, Empatica and Cumulus Neuro. Here is the list of Top 10 competitors of Neurovative Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Longitude Capital & 11 others	69/100
2nd	Empatica 2011, Milano (Italy), Series B	Developer of a wrist band to monitor physiological signals	$30.9M	Sanofi Ventures, RA Capital Management & 5 others	66/100
3rd	Cumulus Neuro 2015, Belfast (United Kingdom), Series A	AI and cloud-based brain physiology analysis tool for clinical trials	$19.6M	Par Equity, Innovate UK & 29 others	61/100
4th	Cortical Labs 2019, Melbourne (Australia), Series A	Manufacturer of AI-powered biochips	$11.6M	Horizons Ventures, January Capital & 9 others	59/100
5th	Beacon Biosignals 2019, Boston (United States), Series B	AI-based EEG analysis and diagnosis platform for healthcare providers	$141M	General Catalyst, Google Ventures & 11 others	58/100
6th	BrainCo 2015, Somerville (United States), Series A	Provider of a prosthetic hand and EEG headband for brain signal	$292M	Walden International, IDG Capital & 10 others	58/100
7th	BrainScope 2006, Bethesda (United States), Series B	Provider of AI-powered non-invasive medical devices for diagnosing and assessing brain injuries, including concussions and brain bleeds	$62.2M	Maryland Venture Fund, Aon & 11 others	58/100
8th	Spark Biomedical 2018, Houston (United States), Series A	Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment	$31.2M	Wave Ventures, Wellcome Leap & 5 others	56/100
9th	Emotiv 2011, San Francisco (United States), Seed	Manufacturer of wireless EEG headsets and software solutions	$7.41M	Disney Accelerator, Korea Credit Guarantee Fund ... & 3 others	56/100
10th	Neurosoft Bioelectronics 2019, Geneva (Switzerland), Seed	Provider of soft implantable electrodes for neurological disorders	$20M	Fongit, IAG Capital Partners & 6 others	55/100
70th	Neurovative Diagnostics 2016, Dallas (United States), Unfunded	Provider of cloud-based neurodiagnostic software for clinicians	-	-	27/100